163 results on '"Mascarell L"'
Search Results
2. Enhancing Allergen-Presentation Platforms for Sublingual Immunotherapy
3. Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patients
4. Characterization of oral immune cells in birch pollen-allergic patients: impact of the oral allergy syndrome and sublingual allergen immunotherapy on antigen-presenting cells
5. Respiratory allergen from house dust mite is present in human milk and primes for allergic sensitization in a mouse model of asthma
6. Evaluation of therapeutic sublingual vaccines in a murine model of chronic house dust mite allergic airway inflammation
7. Macrophage-like cells play a crucial role in tolerance induction via the sublingual route: 80
8. Mapping of the lingual immune system reveals the presence of both regulatory and effector CD4+ T cells
9. Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction
10. Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route
11. Sialylated fetuin-a is a candidate predictive biomarker for successful grass pollen allergen immunotherapy
12. Characterization of epitope specificities of reference antibodies used for the quantification of the birch pollen allergen Bet v 1
13. The regulatory dendritic cell marker C1q is a potent inhibitor of allergic inflammation
14. La Fétuine-A sialylée sérique est un candidat marqueur prédictif de l’efficacité de l’immunothérapie aux allergènes de pollens de graminées
15. Production and characterization of recombinant mature Amb a 11, a new major allergen of short ragweed (Ambrosia artemisiifolia) pollen with a cysteine protease activity
16. Identification dans le sang de patients allergiques aux pollens de graminées d’une signature moléculaire qui corrèle avec l’efficacité clinique de l’immunothérapie allergénique
17. Characterization of epitope specificities of reference antibodies used for the quantification of the birch pollen allergen Bet v 1.
18. Production et caractérisation d’Amb a 11 mature, un nouvel allergène majeur du pollen d’ambroisie (Ambrosia artemisiifolia) avec une activité cystéine protéase
19. Respiratory allergen from house dust mite is present in human milk and primes for allergic sensitization in a mouse model of asthma
20. Cartographie des cellules immunitaires dans la muqueuse buccale de patients allergiques au pollen de bouleau présentant ou non un syndrome d’allergie orale avant et après immunothérapie allergénique par voie sublinguale
21. Identification d’une signature moléculaire spécifique de cellules dendritiques humaines pro-allergiques (de type 2): application au suivi de l’immunothérapie allergénique
22. Respiratory allergen from house dust mite is present in human milk and primes for allergic sensitization in a mouse model of asthma
23. Une induction de cellules dendritiques régulatrices en l’absence de lymphocytes T CD4+ régulateurs, corrèle avec l’efficacité clinique précoce de l’immunothérapie allergénique
24. Anti-inflammatory activity of sublingual immunoglobulin (SLIG) in a murine model of allergen-driven airway inflammation
25. La souche probiotique Bifidobacterium bifidum NCC 453 induit une activité tolérogène dans des modèles murins d’immunothérapie sublinguale
26. Identification de pollens de graminées par immunoempreinte
27. Oral macrophage-like cells play a key role in tolerance induction following sublingual immunotherapy of asthmatic mice
28. Méthodes de caractérisation des extraits allergéniques
29. L’immunothérapie spécifique agit-elle sur l’immunité innée ?
30. Immunité buccale et allergie
31. Adjuvants et formulations de l’immunothérapie spécifique par voie sublinguale
32. Targeting the Allergen to Dendritic Cells with Mucoadhesive Formulations Enhances Tolerance Induction Via the Sublingual Route
33. Delivery of the HIV-1 Tat protein to dendritic cells by the CyaA vector induces specific Th1 responses and high affinity neutralizing antibodies in non human primates
34. The usage of alternative splice sites in mus musculus synaptotagmin-like 2 gene is modulated by cyclosporin A and FK506 in T-lymphocytes
35. Mapping of the lingual immune system reveals the presence of both regulatory and effector CD4+ T cells.
36. Induction of Regulatory T Cells with Sublingual Allergy Vaccines
37. MODERN: Modeling Discourse Entities and Relations for Coherent Machine Translation.
38. Allergen Immunotherapy for the Prevention and Treatment of Asthma.
39. Accurate determination of house dust mite sensitization in asthma and allergic rhinitis through cytometric detection of Der p 1 and Der p 2 binding on basophils (CytoBas).
40. Early increase in serum specific IgG2 upon allergen immunotherapy with a 300 IR sublingual house dust mite tablet.
41. Current advances in house dust mite allergen immunotherapy (AIT): Routes of administration, biomarkers and molecular allergen profiling.
42. Deciphering Differential Behavior of Immune Responses as the Foundation for Precision Dosing in Allergen Immunotherapy.
43. Correlation of serum vitamin D concentration with humoral-specific IgG2 and IgG4 levels in high responders to immunotherapy with a 300 IR sublingual house dust mite tablet.
44. Molecular reactivity profiling upon immunotherapy with a 300 IR sublingual house dust mite tablet reveals marked humoral changes towards major allergens.
45. Coordinated IgG2 and IgE responses as a marker of allergen immunotherapy efficacy.
46. Decrease in CD38 + TH2A cell frequencies following immunotherapy with house dust mite tablet correlates with humoral responses.
47. Bet v 1 contiguous overlapping peptides anchored to virosomes with TLR4 agonist enhance immunotherapy efficacy in mice.
48. Th2A and Th17 cell frequencies and regulatory markers as follow-up biomarker candidates for successful multifood oral immunotherapy.
49. IL-10 mRNA levels in whole blood cells correlate with house dust mite allergen immunotherapy efficacy.
50. Clinical efficacy of sublingual immunotherapy tablets for allergic rhinitis is unlikely to be derived from in vitro allergen-release data.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.